SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-042970
Filing Date
2009-07-13
Accepted
2009-07-13 16:39:06
Documents
9
Period of Report
2009-07-07
Items
Item 5.01: Changes in Control of Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-18176_18k.htm 8-K 41713
2 EX-10.1 a09-18176_1ex10d1.htm EX-10.1 63049
3 EX-10.2 a09-18176_1ex10d2.htm EX-10.2 57895
4 EX-10.3 a09-18176_1ex10d3.htm EX-10.3 51080
5 EX-99.1 a09-18176_1ex99d1.htm EX-99.1 12592
6 GRAPHIC g181761kmi001.jpg GRAPHIC 2803
7 GRAPHIC g181761kqi001.gif GRAPHIC 3272
8 GRAPHIC g181761koi001.gif GRAPHIC 3272
9 GRAPHIC g181761mmi001.gif GRAPHIC 3272
  Complete submission text file 0001104659-09-042970.txt   245957
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 09942232
SIC: 2834 Pharmaceutical Preparations